ID: ALA5274790

Max Phase: Preclinical

Molecular Formula: C13H19NO4

Molecular Weight: 253.30

Associated Items:

Representations

Canonical SMILES:  Cc1cc(=O)c(O)c(CN2CCCC(CO)C2)o1

Standard InChI:  InChI=1S/C13H19NO4/c1-9-5-11(16)13(17)12(18-9)7-14-4-2-3-10(6-14)8-15/h5,10,15,17H,2-4,6-8H2,1H3

Standard InChI Key:  GOAJASKYIIPTGD-UHFFFAOYSA-N

Associated Targets(non-human)

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 253.30Molecular Weight (Monoisotopic): 253.1314AlogP: 0.86#Rotatable Bonds: 3
Polar Surface Area: 73.91Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.43CX Basic pKa: 7.03CX LogP: 0.23CX LogD: 0.06
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.84Np Likeness Score: -0.01

References

1. He M, Fan M, Peng Z, Wang G..  (2021)  An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery.,  221  [PMID:34023737] [10.1016/j.ejmech.2021.113546]

Source